Ybrain Mindsteam Pro /Courtesy of Ybrain

Electronic medicine platform corporations Ybrain said on the 17th that it launched Mindsteam Pro, a higher-end version of the home depression treatment electronic medicine Mindsteam.

Mindsteam is Korea's first home-use electronic medicine for treating depression that delivers transcranial direct current stimulation (tDCS), a microcurrent, to the prefrontal cortex above the forehead via a headset to activate brain function and treat depression. Unlike antidepressants, it is a wearable device rather than a drug, so it has fewer systemic side effects and can be used to treat perinatal depression.

Prescribed as a non-reimbursed treatment in clinical settings since 2023, Mindsteam is now supplied to 174 hospitals in Korea, with cumulative prescriptions exceeding 220,000.

The newly launched Mindsteam Pro further improves the convenience of home treatment by running one 30-minute session per day for six weeks. In a confirmatory clinical trial conducted at six medical institutions in Korea, the remission rate for major depressive symptoms was 62.8%, and the score on the Korean version of the Beck Depression Inventory (K-BDI-II) improved by 47.74%, confirming strong treatment effects even for home care.

Mindsteam Pro consists of a 15-inch touchscreen kiosk, six basic electronic medicine modules, and a personal consumables set. When clinicians enter a patient's prescription into the kiosk, the patient can take the corresponding module home and continue treatment. Compared with the existing Mindsteam, this new product triples the number of basic modules to six and increases consumables tenfold, allowing hospitals to treat more patients at once.

The system can link six modules at once to manage many patients and supports personalized treatment through clinical data accumulation and adherence monitoring. It also enables steady treatment at home through out-of-hospital prescriptions for patients who miss treatment opportunities because frequent and continuous hospital visits are difficult.

Lee Gi-won, CEO of Ybrain, said, "The reason the number of modules increased in this new product is that, with the existing Mindsteam, the higher the number of modules, the higher the proportion of home treatment through out-of-hospital prescriptions," adding, "Mindsteam Pro goes beyond a simple therapeutic device to serve as a core solution that accelerates the digital transformation of psychiatric hospitals and realizes a patient-centered treatment environment, maximizing hospital operational efficiency."

※ This article has been translated by AI. Share your feedback here.